The National Committee for Quality Assurance (NCQA) is accepting comments through March 11 on proposed changes for HEDIS® Measurement Year 2022 (MY 2022), which will be published in August 2021. Jamison Gillitzer, product director for Cotiviti’s quality improvement solutions, summarizes the important details on proposed new measures, changes to existing measures, and measures proposed for retirement for plans that report HEDIS data.
Implement a year-round measurement and reporting program that significantly improves health plan rankings. Learn more about Cotiviti's Quality Intelligence from our fact sheet.
Future of HEDIS
Introduction of Race and Ethnicity Stratification into select HEDIS Measures
NCQA is proposing to introduce race and ethnicity stratifications to five HEDIS measures for MY 2022 with an expansion to a minimum of 15 measures by MY 2024 to help identify and reduce disparities in care. As the agency states, “this effort builds on NCQA’s existing work dedicated to advancing health equity in data and quality measurement.” Candidate measures for MY 2022 include:
- Controlling High Blood Pressure (CBP)
- Comprehensive Diabetes Care (CDC)
- HbA1c <8% indicator
- Eye Exam
- Antidepressant Medication Management (AMM)
- Follow-Up After Emergency Department Visit for People With Multiple High-Risk Chronic Conditions (FMC)
- Adults’ Access to Preventive/Ambulatory Health Services (AAP)
- Prenatal and Postpartum Care (PPC)
- Well-Child Visits in the First 30 Months of Life (W30)
- Child and Adolescent Well-Care Visits (WCV)
- Mental Health Utilization (MPT)
Roadmap for Electronic Clinical Data Systems (ECDS) Reporting Method
NCQA plans to add the ECDS reporting standard to three additional existing measures for MY 2022. As part of a larger strategy to encourage and improve health information exchange, NCQA also proposes removing traditional reporting from measures currently specified for ECDS.
Measure Name |
Summary of Proposed Changes |
---|---|
Childhood Immunization Status (CIS) Immunizations for Adolescents (IMA) Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) |
Allow ECDS reporting for MY 2022 |
Breast Cancer Screening Follow-Up Care for Children Prescribed ADHD Medication (ADD) |
Choose ECDS or Admin reporting for MY 2022, ECDS only MY 2023 |
Colorectal Cancer Screening (COL) |
Choose ECDS or Hybrid reporting for MY 2023, ECDS only MY 2024 (Hybrid removed) |
Cervical Cancer Screening (CCS) |
Add optional ECDS reporting for MY 2023
|
Noting that it will “enable more efficient data exchange, reduce provider burden, and align with other quality measurement use cases,” NCQA is also continuing the gradual transition to the Fast Healthcare Interoperability Resources (FHIR) data model.
Changes to existing HEDIS measures
NCQA is proposing several changes to measures related to acute hospitalization utilization, use of imaging studies for low back pain, mental health utilization, alcohol and drug use, and diabetes care for MY 2022.
Measure Name |
Summary of Proposed Changes |
---|---|
Acute Hospital Utilization (AHU) |
|
Use of Imaging Studies for Low Back Pain (LBP) |
|
Mental Health Utilization (MPT) |
|
Identification of Alcohol and Other Drug Services (IAD) |
|
Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment (IET) |
|
Follow-up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) |
|
Comprehensive Diabetes Care (CDC) |
|
New HEDIS measures being introduced
NCQA is proposing the addition of three new measures for MY 2022.
Measure Name |
Description |
---|---|
Advance Care Planning (ACP) |
|
Deprescribing of Benzodiazepines in Older Adults (DBO) |
|
Antibiotic Utilization for Acute Respiratory Conditions (AXR) |
|
Ready to comment?
NCQA seeks public feedback on these proposed new HEDIS measures, revisions to existing measures, proposed measure retirement, and initiatives by 11:59 p.m. (ET), Thursday, March 11. Submit all comments via NCQA’s Public Comment website.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).